» Articles » PMID: 22609170

Connexins in Atherosclerosis

Overview
Specialties Biochemistry
Biophysics
Date 2012 May 22
PMID 22609170
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Atherosclerosis, a chronic inflammatory disease of the vessel wall, involves multiple cell types of different origins, and complex interactions and signaling pathways between them. Autocrine and paracrine communication pathways provided by cytokines, chemokines, growth factors and lipid mediators are central to atherogenesis. However, it is becoming increasingly recognized that a more direct communication through both hemichannels and gap junction channels formed by connexins also plays an important role in atherosclerosis development. Three main connexins are expressed in cells involved in atherosclerosis: Cx37, Cx40 and Cx43. Cx37 is found in endothelial cells, monocytes/macrophages and platelets, Cx40 is predominantly an endothelial connexin, and Cx43 is found in a large variety of cells such as smooth muscle cells, resident and circulating leukocytes (neutrophils, dendritic cells, lymphocytes, activated macrophages, mast cells) and some endothelial cells. Here, we will systematically review the expression and function of connexins in cells and processes underlying atherosclerosis. This article is part of a Special Issue entitled: The Communicating junctions, roles and dysfunctions.

Citing Articles

Cx43 Facilitates Mesenchymal Transition of Endothelial Cells Induced by Shear Stress.

Zhou E, Zhou J, Bi C, Zhang Z J Vasc Res. 2023; 60(4):204-212.

PMID: 37673049 PMC: 10614473. DOI: 10.1159/000533320.


The Bioactive Phenolic Agents Diaryl Ether CVB2-61 and Diarylheptanoid CVB4-57 as Connexin Hemichannel Blockers.

Dierks A, Vanucci-Bacque C, Schafer A, Lehrich T, Ruhe F, Schadzek P Pharmaceuticals (Basel). 2022; 15(10).

PMID: 36297285 PMC: 9611528. DOI: 10.3390/ph15101173.


Connexin 37 Regulates the Kv1.3 Pathway and Promotes the Development of Atherosclerosis.

Liao M, Chen L, Lu J, Liang G, Yao Y, Ouyang S Mediators Inflamm. 2022; 2022:2689918.

PMID: 36193415 PMC: 9525889. DOI: 10.1155/2022/2689918.


Cardiac Remodelling Following Cancer Therapy: A Review.

Panpan T, Yuchen D, Xianyong S, Meng L, Ruijuan H, Ranran D Cardiovasc Toxicol. 2022; 22(9):771-786.

PMID: 35877038 DOI: 10.1007/s12012-022-09762-6.


Mechanisms of SARS-CoV-2 and Male Infertility: Could Connexin and Pannexin Play a Role?.

Omolaoye T, Jalaleddine N, Cardona Maya W, Du Plessis S Front Physiol. 2022; 13:866675.

PMID: 35721552 PMC: 9205395. DOI: 10.3389/fphys.2022.866675.